stemmacolore
Cerca

A phase IV trial to confirm the efficacy of olaparib in combination with bevacizumab as maintenance frontline treatment of hrd positive ovarian tumours (IOLANTHE)

A phase IV trial to confirm the efficacy of olaparib in combination with bevacizumab as maintenance frontline treatment of hrd positive ovarian tumours (IOLANTHE)

A phase IV trial to confirm the efficacy of olaparib in combination with bevacizumab as maintenance frontline treatment of hrd positive ovarian tumours (IOLANTHE)

Stato
Aperto - reclutamento in corso
Codice studio
IRFMN-OVA-8542 (IOLANTHE)
Codice EudraCT
2022-502242-27-00
Sponsor/Promotore
YMaGiNe (Young MaNGO Gynecologic Network)
Tipologia
Sperimentale
Fase
IV
Unità Operativa
Principal Investigator
Torna in alto